ResearcherCincinnati Childrens Hosp Med CtrActive in the last 2 years
Alisa S. Wolberg
Matched on ORCID iD 0000-0002-2845-2303; OpenAlex author ID A5065937818; NIH RePORTER profile ID 7944095. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 21
2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 grant · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 4
- Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.09.024↗
- Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. Co-author DOI 10.1002/1878-0261.13552↗
- Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma. Co-author DOI 10.18632/oncotarget.7955↗
- Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. Co-author DOI 10.1182/blood-2012-01-402156↗
Grants 1
Closest collaborators
The 21 strongest of 21 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Melissa L. Fishel · 2 shared papers, 1 shared grant, 2022–2026 · strength 0.85
- Grant Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis U01HL143403↗
- Paper Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.09.024↗
- Paper Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. DOI 10.1002/1878-0261.13552↗
- Matthew J. Flick · 2 shared papers, 1 shared grant, 2022–2026 · strength 0.85
- Grant Targeting the Plasminogen Activation System to Limit Pancreatic Cancer Progression and Associated Thrombosis U01HL143403↗
- Paper Depletion of Fibrinogen Suppresses Growth of Primary Tumors and Metastasis of Pancreatic Ductal Adenocarcinoma. DOI 10.1053/j.gastro.2025.09.024↗
- Paper Plasminogen deficiency suppresses pancreatic ductal adenocarcinoma disease progression. DOI 10.1002/1878-0261.13552↗
- Bumsoo Han · 1 shared grant, 2022 · strength 0.45
- Nayela N. Chowdhury · 2 shared papers, 2024–2026 · strength 0.40
- Silpa Gampala · 1 shared paper, 2026 · strength 0.22
- Wei Ping Jia · 1 shared paper, 2026 · strength 0.22
- Sae Rome Choi · 1 shared paper, 2026 · strength 0.22
- Fenil Shah · 1 shared paper, 2024 · strength 0.18
- Yi Yang · 1 shared paper, 2024 · strength 0.18
- Nigel Mackman · 2 shared papers, 2012–2016 · strength 0.07
- Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
- Paper Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreati… DOI 10.1182/blood-2012-01-402156↗
- Vladimir Y. Bogdanov · 2 shared papers, 2012–2016 · strength 0.07
- Paper Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread… DOI 10.18632/oncotarget.7955↗
- Paper Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreati… DOI 10.1182/blood-2012-01-402156↗
- Xiaoyang Qi · 1 shared paper, 2016 · strength 0.05
- Clayton S. Lewis · 1 shared paper, 2016 · strength 0.05
- Syed Ameen Ahmad · 1 shared paper, 2016 · strength 0.05
- Zhengtao Chu · 1 shared paper, 2016 · strength 0.05
- Dusten J. Unruh · 1 shared paper, 2016 · strength 0.05
- Georg F. Weber · 1 shared paper, 2016 · strength 0.05
- Julia E Geddings · 1 shared paper, 2012 · strength 0.03
- Nigel S. Key · 1 shared paper, 2012 · strength 0.03
- Jen Jen Yeh · 1 shared paper, 2012 · strength 0.03
- Jian-Guo Wang · 1 shared paper, 2012 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.